• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中MELK的表达与免疫细胞浸润及新辅助化疗后的病理完全缓解(pCR)相关。

MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.

作者信息

Oshi Masanori, Gandhi Shipra, Huyser Michelle R, Tokumaru Yoshihisa, Yan Li, Yamada Akimitsu, Matsuyama Ryusei, Endo Itaru, Takabe Kazuaki

机构信息

Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center Buffalo, New York 14263, USA.

Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine Yokohama 236-0004, Japan.

出版信息

Am J Cancer Res. 2021 Sep 15;11(9):4421-4437. eCollection 2021.

PMID:34659896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8493385/
Abstract

In experimental settings, maternal embryonic leucine zipper kinase (), an apical member of the snf1/AMPK serine-threonine kinases family, plays a role in tumor growth. We investigated the clinical relevance of expression by performing silico analyses of 7,135 breast cancer patients using multiple independent large cohorts. In triple negative breast cancer (TNBC) found that elevated expression significantly correlates with Nottingham histologic grade and tumor growth according to American Joint Committee Cancer (AJCC) stage. High tumor enriched cell proliferation-related gene sets as well as DNA repair, unfolded protein response, and MTORC signaling gene sets. In two independent cohorts a high mutation rate and worse survival was significantly associated with high tumor. In immune-related gene sets including, allograft rejection, interferon (IFN)-α response, and IFN-γ response, high tumor significantly enriched. Pro-cancer regulatory T cells, T helper type 2 cells and anti-cancer immune cells including CD4 memory T cells, T helper type1 cells, CD8 T cells, M1 macrophages, gamma-delta T cells, and dendritic cells with high levels of cytolytic activity (CYT) were highly infiltrated. expression did not correlate with the responses to any of the drugs tested in cell lines. However, pathologic complete response was significantly associated with high following NAC in both TNBC and ER-positive plus HER2-negative breast cancer. In conclusion, cell proliferation, immune response, and NAC breast cancer response was associated with expression.

摘要

在实验环境中,母体胚胎亮氨酸拉链激酶()是snf1/AMPK丝氨酸 - 苏氨酸激酶家族的顶端成员,在肿瘤生长中发挥作用。我们通过使用多个独立的大型队列对7135例乳腺癌患者进行计算机分析,研究了 表达的临床相关性。在三阴性乳腺癌(TNBC)中发现,根据美国癌症联合委员会(AJCC)分期, 表达升高与诺丁汉组织学分级和肿瘤生长显著相关。高 肿瘤富含细胞增殖相关基因集以及DNA修复、未折叠蛋白反应和MTORC信号基因集。在两个独立队列中,高 肿瘤与高突变率和较差的生存率显著相关。在包括同种异体移植排斥、干扰素(IFN)-α反应和IFN-γ反应的免疫相关基因集中,高 肿瘤显著富集。具有高细胞溶解活性(CYT)的促癌调节性T细胞、2型辅助性T细胞和抗癌免疫细胞,包括CD4记忆T细胞、1型辅助性T细胞、CD8 T细胞、M1巨噬细胞、γδ T细胞和树突状细胞高度浸润。 表达与细胞系中测试的任何药物的反应均无相关性。然而,在TNBC和雌激素受体阳性加人表皮生长因子受体2阴性乳腺癌中,病理完全缓解与新辅助化疗后高 显著相关。总之,细胞增殖、免疫反应和新辅助化疗乳腺癌反应与 表达相关。

相似文献

1
MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.乳腺癌中MELK的表达与免疫细胞浸润及新辅助化疗后的病理完全缓解(pCR)相关。
Am J Cancer Res. 2021 Sep 15;11(9):4421-4437. eCollection 2021.
2
A novel five-gene score to predict complete pathological response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.一种用于预测雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌新辅助化疗完全病理缓解的新型五基因评分。
Am J Cancer Res. 2021 Jul 15;11(7):3611-3627. eCollection 2021.
3
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.母系胚胎亮氨酸拉链激酶与三阴性乳腺癌转移相关。
Cancer Res Commun. 2023 Jun 20;3(6):1078-1092. doi: 10.1158/2767-9764.CRC-22-0330. eCollection 2023 Jun.
4
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.母源胚胎亮氨酸拉链激酶(MELK)作为人乳腺癌放射抗性的新型介质和生物标志物
Clin Cancer Res. 2016 Dec 1;22(23):5864-5875. doi: 10.1158/1078-0432.CCR-15-2711. Epub 2016 May 25.
5
Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.活性氧(ROS)的大量存在与乳腺癌的侵袭性、免疫反应和较差的生存有关。
Breast Cancer Res Treat. 2022 Jul;194(2):231-241. doi: 10.1007/s10549-022-06633-0. Epub 2022 May 31.
6
A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.一种新型三基因评分作为三阴性乳腺癌新辅助化疗后病理完全缓解的预测生物标志物
Cancers (Basel). 2021 May 16;13(10):2401. doi: 10.3390/cancers13102401.
7
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.调节性T细胞(Treg)丰度作为三阴性乳腺癌新辅助化疗的预测生物标志物
Cancers (Basel). 2020 Oct 19;12(10):3038. doi: 10.3390/cancers12103038.
8
High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer.NRF2的高表达与雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌中肿瘤浸润淋巴细胞增加及癌症免疫相关。
Cancers (Basel). 2020 Dec 21;12(12):3856. doi: 10.3390/cancers12123856.
9
MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.MELK作为控制三阴性乳腺癌MDA-MB-231细胞增殖的潜在靶点。
Oncol Lett. 2018 Jun;15(6):9934-9940. doi: 10.3892/ol.2018.8543. Epub 2018 Apr 20.
10
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.母源胚胎亮氨酸拉链激酶(MELK)通过与Bcl-2家族的促凋亡成员Bcl-G相互作用参与乳腺癌发生。
Breast Cancer Res. 2007;9(1):R17. doi: 10.1186/bcr1650.

引用本文的文献

1
Enhanced glycolysis is associated with aggressive tumor phenotype and worse outcomes in hepatocellular carcinoma patients.糖酵解增强与肝细胞癌患者的侵袭性肿瘤表型及较差预后相关。
Front Med (Lausanne). 2025 Aug 26;12:1588604. doi: 10.3389/fmed.2025.1588604. eCollection 2025.
2
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.间皮素(MSLN)在三阴性乳腺癌中高表达,并与细胞增殖增强和促炎性肿瘤微环境相关。
Ann Surg Oncol. 2025 Jun;32(6):4476-4486. doi: 10.1245/s10434-025-17117-y. Epub 2025 Mar 13.
3
MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer.MELK作为侵袭性亚型乳腺癌干性和转移的介质
Int J Mol Sci. 2025 Mar 3;26(5):2245. doi: 10.3390/ijms26052245.
4
Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy.评估动态对比增强磁共振成像在接受新辅助化疗的患者中鉴别HER2阴性、HER2低表达和HER2阳性乳腺癌的价值。
Eur J Med Res. 2025 Feb 25;30(1):132. doi: 10.1186/s40001-024-02188-6.
5
Activity-Regulated Cytoskeleton-Associated Protein Gene Expression Is Associated With High Infiltration of Stromal Cells and Immune Cells, but With Less Cancer Cell Proliferation and Better Overall Survival in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers.活性调节细胞骨架相关蛋白基因表达与基质细胞和免疫细胞的高浸润相关,但与雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌中的癌细胞增殖较少及总生存期较好相关。
World J Oncol. 2025 Feb;16(1):16-29. doi: 10.14740/wjon1936. Epub 2025 Jan 13.
6
Markers of Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: New in Molecular Oncology.乳腺癌新辅助化疗反应预测标志物:分子肿瘤学的新进展。
Asian Pac J Cancer Prev. 2024 Nov 1;25(11):3761-3769. doi: 10.31557/APJCP.2024.25.11.3761.
7
Targeting MELK in tumor cells and tumor microenvironment: from function and mechanism to therapeutic application.靶向肿瘤细胞和肿瘤微环境中的MELK:从功能与机制到治疗应用
Clin Transl Oncol. 2025 Mar;27(3):887-900. doi: 10.1007/s12094-024-03664-5. Epub 2024 Aug 26.
8
Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer.MELK的上调通过CSF-1/JAK2/STAT3途径促进胃癌的化疗耐药并诱导巨噬细胞M2极化。
Cancer Cell Int. 2024 Aug 12;24(1):287. doi: 10.1186/s12935-024-03453-8.
9
Deciphering the miRNA-mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach.解析乳腺癌与三阴性乳腺癌之间的miRNA-mRNA相互作用图谱:一种综合生物信息学方法。
ACS Omega. 2024 May 29;9(23):24379-24395. doi: 10.1021/acsomega.4c00011. eCollection 2024 Jun 11.
10
Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.靶向MELK通过增强抗肿瘤免疫力提高宫颈癌中PD-1阻断的效率。
Mol Ther Oncol. 2024 Jan 10;32(1):200759. doi: 10.1016/j.omton.2024.200759. eCollection 2024 Mar 21.

本文引用的文献

1
Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.炎症与全队列患者的不良结局相关,但与三阴性乳腺癌患者的更好结局相关。
J Immunol Res. 2020 Dec 8;2020:5618786. doi: 10.1155/2020/5618786. eCollection 2020.
2
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future.乳腺癌的新辅助化疗:过去、现在与未来
Breast Cancer (Auckl). 2020 Dec 16;14:1178223420980377. doi: 10.1177/1178223420980377. eCollection 2020.
3
High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer.NRF2的高表达与雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌中肿瘤浸润淋巴细胞增加及癌症免疫相关。
Cancers (Basel). 2020 Dec 21;12(12):3856. doi: 10.3390/cancers12123856.
4
Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer.早期雌激素反应程度可预测原发性和转移性雌激素受体阳性乳腺癌内分泌治疗后的生存率。
Cancers (Basel). 2020 Nov 28;12(12):3557. doi: 10.3390/cancers12123557.
5
Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC).浆细胞样树突状细胞(pDC)浸润与三阴性乳腺癌(TNBC)中的肿瘤浸润淋巴细胞、癌症免疫及更好的生存率相关,且这种相关性比传统树突状细胞(cDC)更强。
Cancers (Basel). 2020 Nov 12;12(11):3342. doi: 10.3390/cancers12113342.
6
MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer.MYC 靶点评分与 ER 阳性原发性和转移性乳腺癌的癌症侵袭性和不良生存相关。
Int J Mol Sci. 2020 Oct 30;21(21):8127. doi: 10.3390/ijms21218127.
7
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.调节性T细胞(Treg)丰度作为三阴性乳腺癌新辅助化疗的预测生物标志物
Cancers (Basel). 2020 Oct 19;12(10):3038. doi: 10.3390/cancers12103038.
8
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.基于转录组特征定义的 M1 巨噬细胞和 M1/M2 比值仅部分类似于乳腺癌的传统临床特征。
Sci Rep. 2020 Oct 6;10(1):16554. doi: 10.1038/s41598-020-73624-w.
9
ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.ITPKC作为三阴性乳腺癌新辅助化疗的预后和预测生物标志物
Cancers (Basel). 2020 Sep 25;12(10):2758. doi: 10.3390/cancers12102758.
10
CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.CD8 T 细胞评分作为三阴性乳腺癌的预后生物标志物。
Int J Mol Sci. 2020 Sep 22;21(18):6968. doi: 10.3390/ijms21186968.